Arax Advisory Partners’s TuHURA Biosciences HURA Stock Holding History

Arax Advisory Partners’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.9K	Buy	15,344 +15,085	+5,824%	+$35.1K	﹤0.01%	3538
2026 Q1	$464	Buy	+259	New	+$317	﹤0.01%	3425
2025 Q4	–	Sell	-1,551	Closed	-$3.85K	–	4610
2025 Q3	$3.85K	Buy	+1,551	New	+$4.08K	﹤0.01%	2948

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arax Advisory Partners's HURA Position: Q2 2026 in Review

Arax Advisory Partners increased its TuHURA Biosciences (HURA) stake by 5,824% in Q2 2026, buying an estimated $35.1K and bringing the position to 15,344 shares worth $35.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3538.

Arax Advisory Partners first reported a position in HURA in Q3 2025 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Arax Advisory Partners held 15,344 shares of TuHURA Biosciences worth $35.9K as of Q2 2026.
Arax Advisory Partners bought 15,085 TuHURA Biosciences shares in Q2 2026, an estimated $35.1K.
TuHURA Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3538 holding.
Arax Advisory Partners first reported a position in TuHURA Biosciences in Q3 2025 and has held it in 3 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.